<none>
Steven C. Schachter, MD, received a special honor in India when he delivered the 28th T.S. Srinivasan Endowment Oration in Chennai on “Brainstorms Village-Meeting the Challenge of Disabling Epilepsy.” Quoted in India’s national newspaper, The...
When a Food and Drug Administration (FDA) alert was issued regarding antiepileptic drugs and suicidality, epilepsy.com responded with a Breaking News story and several articles to help patients put the findings in context. FDA Alert , 3 articles...
It was announced on February 27, 2008 that the U.S. Food and Drug Administration (FDA) has accepted Ovation Pharmaceuticals’ new drug applications (NDA) for Sabril® (vigabatrin) in two types of epilepsies. The FDA assigned a priority NDA review for...
On January 14, 2008 Dr. Steven Schachter was guest expert for a question and answer chat on seizure medicines. The purpose of this session was to provide general information and resources. These answers and the information on epilepsy.com are not...
The FDA has issued an alert highlighting concerns that AEDS (called antiepileptic drugs) used for epilepsy may increase the risk of suicidal feelings or behaviors in people taking many of these drugs. This report examined results of some studies...

Pages